Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
25,296,136
-
Total 13F shares
-
1,130,141
-
Share change
-
+1,032,453
-
Total reported value
-
$77,574
-
Price per share
-
$0.07
-
Number of holders
-
15
-
Value change
-
+$70,823
-
Number of buys
-
10
Institutional Holders of Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI) as of Q1 2025
As of 31 Mar 2025,
Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,130,141 shares.
The largest 10 holders included
JANE STREET GROUP, LLC, HRT FINANCIAL LP, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, TWO SIGMA SECURITIES, LLC, VANGUARD GROUP INC, BlackRock, Inc., MORGAN STANLEY, and SBI Securities Co., Ltd..
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.